Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 8 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 15 analysts offering 12 month price targets for Madrigal Pharmaceuticals Inc have a median target of 390.00, with a high estimate of 530.00 and a low estimate of 155.00. The median estimate represents a 11.21% increase from the last price of 350.70.
High | 51.1% | 530.00 |
Med | 11.2% | 390.00 |
Low | -55.8% | 155.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | -0.45% |
Average growth rate | -46.43% |
More ▼
Revenue history & estimates in USD
Average growth rate | +108.25% |
Average growth rate | 0.00% |
More ▼